Overcoming methotrexate resistance by a lipophilic antifolate (BW 301U): from theory to models to practice
- 31 December 1985
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 24, 357-375
- https://doi.org/10.1016/0065-2571(85)90086-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- Unstable Methotrexate Resistance in Human Small-Cell Carcinoma Associated with Double Minute ChromosomesNew England Journal of Medicine, 1983
- Synthesis and antitumor activity of 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidineJournal of Medicinal Chemistry, 1980
- Acquired methotrexate resistance in lymphoblasts resulting from altered kinetic properties of dihydrofoltate reductasePublished by Elsevier ,1977
- New Approaches to Cancer Chemotherapy with MethotrexateNew England Journal of Medicine, 1975
- Methodichlorophen as anti-tumor drug.BMJ, 1975
- PYRIMETHAMINE IN PROPHYLAXIS OF MENINGEAL LEUKAEMIAThe Lancet, 1974
- PYRIMETHAMINE IN CENTRAL-NERVOUS-SYSTEM LEUKÆMIAThe Lancet, 1973
- PYRIMETHAMINE IN CENTRAL-NERVOUS-SYSTEM LEUKÆMIAThe Lancet, 1973
- Studies on dihydrofolate reductase related to the drug sensitivity of microbial and neoplastic cellsAdvances in Enzyme Regulation, 1968